1. Home
  2. RVYL vs ICU Comparison

RVYL vs ICU Comparison

Compare RVYL & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RVYL

Ryvyl Inc.

HOLD

Current Price

$7.81

Market Cap

8.5M

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

N/A

Current Price

$3.07

Market Cap

9.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVYL
ICU
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
9.1M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
RVYL
ICU
Price
$7.81
$3.07
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.4K
70.7K
Earning Date
04-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,131,000.00
N/A
Revenue This Year
$770.54
$53.00
Revenue Next Year
N/A
$50.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.22
52 Week High
$8.55
$5.10

Technical Indicators

Market Signals
Indicator
RVYL
ICU
Relative Strength Index (RSI) 67.46 30.23
Support Level $5.00 $2.26
Resistance Level $8.55 $4.96
Average True Range (ATR) 0.65 0.28
MACD 0.11 -0.11
Stochastic Oscillator 96.06 2.66

Price Performance

Historical Comparison
RVYL
ICU

About RVYL Ryvyl Inc.

Ryvyl Inc is a financial technology company that provides payment acceptance and disbursement solutions, mainly enabling merchants to process credit card transactions through BIN sponsorship arrangements with acquiring banks and payment processors, where it operates as an intermediary performing functions such as merchant underwriting, onboarding, risk monitoring, and customer support. The company also offers its internally developed NEMS Core platform, which facilitates automated inbound and outbound disbursements through a modular workflow system.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: